ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

SER Serina Therapeutics Inc

10.00
0.25 (2.56%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,742
Bid Price
Ask Price
News -
Day High 10.89

Low
7.86

52 Week Range

High
19.93

Day Low 9.52
Company Name Stock Ticker Symbol Market Type
Serina Therapeutics Inc SER AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.25 2.56% 10.00 16:51:22
Open Price Low Price High Price Close Price Prev Close
9.70 9.52 10.89 10.00 9.75
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
170 2,742 $ 10.24 $ 28,078 - 7.86 - 19.93
Last Trade Time Type Quantity Stock Price Currency
20:00:00 688 $ 10.00 USD

Serina Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
81.7M 8.41M - 142k -14.8M -1.76 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Serina Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SER Message Board. Create One! See More Posts on SER Message Board See More Message Board Posts

Historical SER Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.5210.899.009.4811,0490.485.04%
1 Month8.5412.97827.869.4019,1701.4617.10%
3 Months11.6819.937.8610.2410,134-1.68-14.38%
6 Months11.6819.937.8610.2410,134-1.68-14.38%
1 Year11.6819.937.8610.2410,134-1.68-14.38%
3 Years11.6819.937.8610.2410,134-1.68-14.38%
5 Years11.6819.937.8610.2410,134-1.68-14.38%

Serina Therapeutics Description

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

Your Recent History

Delayed Upgrade Clock